BNP PARIBAS FINANCIAL MARKETS - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$694,348
+13.4%
193,952
+16.9%
0.00%0.0%
Q2 2023$612,381
-56.1%
165,957
-60.6%
0.00%
-50.0%
Q1 2023$1,395,880
+92.9%
421,716
+126.1%
0.00%
+100.0%
Q4 2022$723,740
-99.9%
186,531
-22.2%
0.00%0.0%
Q3 2022$582,357,000
+601.9%
239,653
+472.0%
0.00%
Q2 2022$82,964,000
+3728.5%
41,901
+3438.9%
0.00%
Q1 2022$2,167,000
+29.8%
1,1840.0%0.00%
Q4 2021$1,669,000
+6.4%
1,184
-14.7%
0.00%
Q3 2021$1,568,000
-37.7%
1,388
-11.8%
0.00%
Q2 2021$2,517,000
-85.4%
1,573
-83.9%
0.00%
Q1 2021$17,225,000
-31.8%
9,787
-24.4%
0.00%
Q4 2020$25,252,000
-26.8%
12,950
-10.2%
0.00%
Q3 2020$34,483,000
+299.5%
14,428
+389.7%
0.00%
Q2 2020$8,632,000
-85.8%
2,946
-86.0%
0.00%
Q1 2020$60,676,000
+159.3%
21,068
+260.2%
0.00%
Q4 2019$23,396,000
-17.5%
5,849
-8.2%
0.00%
Q3 2019$28,346,000
+206.6%
6,370
+166.6%
0.00%
Q2 2019$9,245,000
-40.7%
2,389
-41.9%
0.00%
Q1 2019$15,596,0004,1150.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 4,000,000$13,240,00011.29%
Stonepine Capital Management, LLC 7,661,690$25,360,1948.50%
Altium Capital Management LP 2,870,000$9,499,7005.27%
Caligan Partners LP 1,662,613$5,503,2493.84%
AWM Investment Company, Inc. 6,015,000$19,909,6502.69%
Perceptive Advisors 11,900,255$39,389,8441.16%
EAM Investors, LLC 1,035,752$3,428,3390.67%
OBERWEIS ASSET MANAGEMENT INC/ 1,169,500$3,871,0450.60%
Magnetar Financial LLC 7,074,722$23,417,3300.46%
Virtus ETF Advisers LLC 83,925$277,7920.15%
View complete list of ADMA BIOLOGICS INC shareholders